NMHC 50 Lists Show Continued Apartment Demand
Kiadis Pharma’s Pediatric Investigation Plan for ATIR101™ accepted by the European Medicines Agency’s Pediatric Committee
Kiadis Pharma Announces Annual Results for the Year Ended December 31, 2016
Acorda Announces Long-Term Safety Data for CVT-301
Clovis Oncology Announces Data Presentations at AACR Annual Meeting 2017
The information and opinions presented herein are not meant to be taken as investment advice. We do our best to make sure the information presented in this article is factual and correct, but Zacks cannot be held responsible for any losses incurred from investment transactions made based on ...